MALATEQ
film-coated tablets 12
registration number
47/20.2.6/1015
What MALATEQ is and what it is used for
MALATEQ is indicated for the prophylaxis of drug-sensitive and drug-resistant Plasmodium falciparum malaria.
Official guidelines and local information on the prevalence of resistance to antimalarial medicines should be taken into consideration.
dosage
Dosage in adults:
One MALATEQ film coated tablet daily.
Dosage in the elderly:
No dose adjustments are needed in the elderly.
Dosage in hepatic impairment:
No dosage adjustments are needed in patients with mild to moderate hepatic impairment. No studies have been conducted in patients with severe hepatic impairment.
Dosage in renal impairment:
No dosage adjustments are needed in patients with mild to moderate renal impairment.
how to take
The daily dose should be taken with food or milk at the same time each day.
Should vomiting occur within 1 hour of dosing, a repeat dose should be taken.
Prophylaxis:
Prophylaxis should start 1 to 2 days before entering a malaria-endemic area, and be continued daily until 7 days after leaving the area.
What MALATEQ contains
Each film coated tablet contains 250 mg atovaquone and 100 mg proguanil hydrochloride.
other ingredients
Colloidal silicon dioxide, hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, Opadry brown (ferric oxide, hydroxypropyl methylcellulose, polyethylene glycol, titanium dioxide), poloxamer 188, povidone and sodium starch glycolate.
Therapeutic classification
A 20.2.6 Medicines against protozoa.